Overview
Location
United States, Indiana, York
Employees
51-200
Total raised
$19M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 23, 2014 | Merck Acquired OncoEthix | Global healthcare leader Merck (NYSE:MRK) acquired OncoEthix, a Swiss-based privately held biotechnology company specializing in oncology drug development. Financial terms of the acquisition include an upfront payment of up to $110m to Onco... |
| Dec 19, 2014 | Merck Acquires OncoEthix | |
| Jul 8, 2013 | OncoEthix Closes 18 Million CHF Series B Financing | |
| Jul 8, 2013 | OncoEthix Closes $19M Series B Financing | OncoEthix, a Lausanne, Switzerland-based oncology drug development company, closed a CHF18m Series B financing (approximately US$19m). The round was led by SV Life Sciences, with participation from new investor Edmond de Rothschild Investme... |
| Mar 20, 2013 | OncoEthiX drug against blood cancer tested in patients | |
| Jun 18, 2012 | OncoEthix In-Licenses anticancer compound |
Reviews 0
FAQ about OncoEthix’
How much funding has OncoEthix’ raised?
OncoEthix’ has raised $19M in total across 1 funding round.
What has the press written about OncoEthix’?
Parsers VC has collected 7 articles mentioning OncoEthix’, among them “Merck Acquired OncoEthix” (Dec 23, 2014) and “Merck Acquires OncoEthix” (Dec 19, 2014).
Is OncoEthix’ still active?
OncoEthix’ is probably closed: its latest activity on Parsers VC dates from Sep 7, 2015.